pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

European Pharmaceutical Review

AUGUST 21, 2023

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1

Biopharma 98

Biopharma Marketing Sales Medicine 98

LEVO Health

JANUARY 31, 2023

Therefore, it is essential to become familiar with the role SEO strategy plays in healthcare marketing and healthcare SEO best practices that should be employed in 2023 to create a successful digital marketing plan. Keywords that are too general will lead to more competition and a less targeted audience.

Healthcare 96

Healthcare Healthcare Marketing Engineering 96

PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

European Pharmaceutical Review

JANUARY 10, 2023

Clarivate Plc has released its Drugs to Watch 2023 report — among 70 of the drugs highlighted, including potential blockbuster drugs, the majority were revealed to be personalised medicines. The report offers predictive analysis of drugs entering the market or launching key indications in 2023. Drug development in 2023 and beyond.

Food and Drug Administration 98

Food and Drug Administration FDA Food Medicine 98

pharmaphorum

JANUARY 9, 2023

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Medicine 98

Medicine Healthcare Healthcare Pharma 98

European Pharmaceutical Review

JANUARY 9, 2023

Record levels of deal-making Firepower, a company’s capacity to do M&A based on the strength of its balance sheet, is available for the life sciences sector, according to EY’s 2023 M&A Firepower report. M&A predictions for 2023. Global M&A activity in 2022.

Biopharma 98

Biopharma Specialization Leads Competition 98

LEVO Health

DECEMBER 20, 2022

As 2023 approaches, there are several strategies you can adopt to improve your healthcare marketing efforts and grow your practice. Adopting the following six marketing strategies may help you stay competitive, bring in new patients, and grow your practice substantially. 6 Medical Marketing Strategies to Adopt in 2023.

Healthcare 98

Healthcare Healthcare Marketing Media 98

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market.

FDA 98

FDA Healthcare Healthcare Medicine 98

pharmaphorum

JANUARY 27, 2023

It’s wise advice from the “Sage of Omaha”; indeed, one highly respected financial newspaper began its 2023 predictions by conceding that it had been wrong on five major counts for 2022. In any case, there is only so much that companies can do on their own – which brings us to the third likely trend for 2023. The impact is two-fold.

Medicine 105

Medicine Government Marketing Transportation 105

European Pharmaceutical Review

FEBRUARY 7, 2023

A wave of important legislative changes is anticipated in the EU in 2023 making this year one of the biggest for the EU regulatory landscape governing the life sciences industry in recent times. As a key priority action under the ACT EU initiative, EU regulators plan to establish a multi-stakeholder platform (MSP) in 2023.

Medical 117

Medical Government Marketing Medicine 117

Star OUTiCO

NOVEMBER 30, 2022

January is one of the busiest recruiting times, so starting your hunt this month could mean lower competition and possibly improve your odds of securing your dream job. Reassess ahead of 2023. The post Top tips for finding a new job in 2023 appeared first on Star OUTiCO.

Recruitment 98

Recruitment Pharma Leads Competition 98

Copyright Clearance Center

MAY 16, 2023

May 16, 2023 – Danvers, Mass. – Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries. Nicknamed the “Stevies” for the Greek word meaning “crowned,” the competition receives over 12,000 entries each year from organizations in 70 countries.

Competition 98

Competition Sales 98

pharmaphorum

JANUARY 5, 2023

As Chancellor of the Exchequer Jeremy Hunt said: “I want British firms to lead the world in turning fantastic science into new products and services – and we need to make sure government is doing everything we can to encourage innovation and competition.”. The post It’s time for more tech and biotech innovation in 2023 appeared first on.

Manufacturing 105

Manufacturing Government Leads Electronics 105

European Pharmaceutical Review

JANUARY 11, 2024

billion, so biosimilar competition could significantly expand patient access to this biologic therapy within the fields of gastroenterology, dermatology, and rheumatology, according to STADA and Alvotech. The EU ustekinumab market is worth €2.5 In this region, STADA already has six biosimilars approved in this market.

Competition 115

Competition Marketing Safety Manufacturing 115

Contrarian Sales Techniques

DECEMBER 31, 2023

Reflecting on 2023 2023 has been a year like no other. Highlights of the Year 2023 has been a transformative year in the world of sales, marked by significant advancements and innovations. The Power of Adaptability : If there's one thing 2023 has taught us, it's the importance of adaptability in sales.

Sales 64

Sales Sales Strategy Ethics Media 64

European Pharmaceutical Review

NOVEMBER 30, 2023

Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

PM360

APRIL 7, 2023

However, we expect drugs without strong therapeutic alternatives to have an advantage in negotiations, while drugs in highly competitive classes will be negotiating from a weaker position. Expect the nine competitors to explore Kotler’s 4Ps of Marketing to gain share in this lucrative and competitive marketplace.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

World of DTC Marketing

MARCH 17, 2021

Pharma has gone to court again and again to delay generic competition of biologic drugs. One company AbbVie has used the courts to stop competition of its top drug Humira. sales until at least 2023 because 257 patent filings stand in the way. In fact, Richard Gonzalez, C.E.O.

Pharma 186

Pharma Competition Prescription Sales 186

Clarify Health

NOVEMBER 15, 2021

By 2023, available annual profit pools will range from $11 billion to $13 ­billion, making Medicare Advantage the single biggest driver of profit growth for health care insurance providers ¹. For one national health plan, the strategy to improve and expand their Medicare Advantage networks was built upon meeting competitive overlap targets.

Networking 52

Networking Competition Insurance Marketing 52

Clarivate

DECEMBER 19, 2022

For 2023 Medicare Advantage open enrollment, the United States’ largest retailer will begin a 10-year partnership with the nation’s largest insurer. The partnership dovetails with Walmart Health’s plans for 15 new Florida clinics across the Jacksonville, Orlando and Tampa markets by the end of 2023. MA national enrollment.

Competition 52

Competition Retail Insurance Marketing 52

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.”

Competition 118

Competition Consulting Marketing Pharma 118

European Pharmaceutical Review

OCTOBER 10, 2023

The current Voluntary Scheme is due to end in December 2023. Unprecedented high payment rates in 2022 and 2023 have had a demonstrable impact on our ability to operate sustainably in the UK. Without a new deal agreed, all branded medicines sales will, for the first time, be subject to the statutory scheme, ABPI warned.

Medicine 111

Medicine Pharma Government Competition 111

pharmaphorum

AUGUST 17, 2022

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. Indicators from the 2000s were captured in the Pharmaceutical Industry Competitiveness Task Force (PICTF) Indicators. The post UK life science competitiveness indicators 2022: measuring what matters most?

Competition 59

Competition Medicine Patients Government 59

European Pharmaceutical Review

NOVEMBER 30, 2023

The company stated that based on the IQVIA’s 2022 report: The impact of biosimilar competition in Europe , as of 2022 “the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5

Marketing 111

Marketing Medicine Competition Distribution 111

European Pharmaceutical Review

APRIL 11, 2024

percent CAGR between 2023 and 2032. This has resulted in “increased competition and price pressure, driving the growth of the biosimilar market”. The latter of which is important in “gaining a competitive advantage”, the author noted. million by 2032, at 17.6

Marketing 105

Marketing Competition Manufacturing Medicine 105

MedReps

JANUARY 30, 2023

If you know how to prepare and get ahead of your competition, reaching your goals will be that much easier. Medical Sales Trends to Watch Out For in 2023 If you want to know what the future holds and create some forward-thinking sales goals, then check out these medical sales trends to watch out for in 2023.

Medical sales 74

Medical sales Medical Sales Sales goal 74

Clarify Health

JUNE 29, 2023

Ideon will power Clarify Networks’ competitive intelligence software module with national insurance network data across commercial, Affordable Care Act (ACA), and Medicare Advantage (MA) markets to empower health plans to gain valuable insights into their competitors’ networks.

Networking 52

Networking Competition Insurance Healthcare 52

European Pharmaceutical Review

OCTOBER 4, 2023

Sandoz to move headquarters to Basel, Switzerland Completion of the spin-off on the 4 October 2023 marks “a new era for Sandoz as an independent company” noted Sandoz’s Board Chairman, Gilbert Ghostine. To prepare for the separation, Sandoz stated in June that its headquarters would transfer to Basel, Switzerland.

Medicine 105

Medicine CRM Pharmaceutical Competition 105

Spotio

JUNE 13, 2023

However, some sales leaders are now using leaderboards to encourage healthy competition in their teams and reward sales reps who hit their goals. Having a team leaderboard that’s visible to the entire team is the perfect way to create some healthy in-house competition amongst your sales reps.

Management 92

Management Sales Sales Management Sales territory 92

European Pharmaceutical Review

JULY 21, 2023

Supporting European biosimilar development Continued investment in biosimilars The planned financing builds on Sandoz’s announced investment in March 2023 of $400 million in a new biologics manufacturing plant in Lendava, Slovenia. This was the largest-ever international private-sector investment in the country, according to the company.

Biopharma 98

Biopharma Manufacturing Competition Healthcare 98

Spotio

FEBRUARY 6, 2023

In this post, we’ll talk about what sales enablement is and why it’s important, then we’ll share our list of the 62 best sales enablement tools available in 2023. Aloware Sales teams tend to adapt to newer technologies including sales tools that can cope with the increasing competition across various industries over time.

Sales 98

Sales CRM Training Leads 98

European Pharmaceutical Review

JANUARY 29, 2024

According to Medicines for Europe, the Munich District Court’s Supplementary Protection Certificate (SPC) manufacturing waiver , issued in Germany in October 2023, is “in conflict” with the objectives of the waiver. The organisation and its members are “strongly concerned” by the court’s first judgement of the waiver.

Medicine 98

Medicine Manufacturing Competition Marketing 98

Clarivate

DECEMBER 18, 2023

As 2023 comes to a close , make sure you don’t miss out on the timely insights from Clarivate , created to help IP legal teams plan for the rapidly changing industry. As IP legal teams strategically navigated 2023 Clarivate created resources to help, backed by insights from industry experts.

Specialization 59

Specialization Management Consulting Professional Services 59

Spotio

JULY 25, 2023

Source ) Alignment between sales and user intent Understanding the customer journey is a critical aspect of B2B sales, especially in a highly competitive field. The B2B customers of today have greater access to information online and offline – and they’re putting it to good use. 9-Step B2B Sales Process Now let’s see how to sell B2B.

B2B Sales 98

B2B Sales Sales Prospecting Sales process 98

Pharmaceutical Technology

MAY 11, 2023

The global pharma industry experienced a 9% drop in social media posts on internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for U.S. Centers for Disease Control and Prevention had the most mentions of internet of things in Q1 2023. Buy the report here.

Media 52

Media Pharma Competition Marketing 52

Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced a 17% rise in company filings mentions of blockchain in Q1 2023 compared with the previous quarter, with the highest share accounted for by Bayer, according to GlobalData’s analysis of over 60 pharmaceutical company filings. The overall index for blockchain in Q1 2023 was 74.

Pharmaceutical 52

Pharmaceutical Marketing Competition Medicine 52